Fonar Q1 2025 EPS $0.46 Down From $0.59 YoY, Sales $24.96M Down From $25.84M YoY
Fonar Q1 2025 EPS $0.46 Down From $0.59 YoY, Sales $24.96M Down From $25.84M YoY
福納2025年第一季度每股收益爲0.46美元,較去年同期的0.59美元下降,銷售額爲2496萬美元,較去年同期的2584萬美元下降
- Total MRI scan volume at the HMCA-managed sites increased 5% to 53,054 scans for the quarter ending September 30, 2024 versus the corresponding quarter one year earlier.
- Cash and cash equivalents decreased 4% to $54.2 million at September 30, 2024 as compared to the fiscal year-ended June 30, 2024.
- Total Revenues - Net decreased by 3% to $25.0 million for the quarter ended September 30, 2024 versus the corresponding quarter one year earlier.
- Income from Operations decreased 30% to $4.6 million for the quarter ended September 30, 2024 versus the corresponding quarter one year earlier.
- Net Income decreased 25% to $4.0 million for the quarter ended September 30, 2024 versus the corresponding quarter one year earlier.
- Diluted Net Income per Common Share decreased 22% to $0.46 for the quarter ended September 30, 2024 versus the corresponding quarter one year earlier.
- Working Capital increased by 2% to $124.7 million at September 30, 2024 as compared to the fiscal year-ended June 30, 2024.
- Book Value Per Share was $25.32 for the quarter ended September 30, 2024 as compared to $23.88 at September 30, 2023.
- One HMCA-managed MRI scanner was added in the first quarter of fiscal 2024, bringing the total number of managed scanners to 43.
- HMCA管理的診所總MRI掃描量增加了5%,達到53,054次,截至2024年9月30日,與一年前的同一季度相比。
- 截至2024年9月30日,現金及現金等價物下降4%至$5420萬,與截至2024年6月30日的財政年度相比。
- 截至2024年9月30日的季度總營收-淨利潤下降了3%,至$2500萬,與一年前的同一季度相比。
- 截至2024年9月30日的季度營業利潤下降了30%,至$460萬,與一年前的同一季度相比。
- 淨利潤下降了25%,至$400萬,截至2024年9月30日的季度,與一年前的同一季度相比。
- 每股攤薄後淨收入下降了22%,至$0.46,截至2024年9月30日的季度,與一年前的同一季度相比。
- 截至2024年9月30日,營運資本增加了2%,至$12470萬,與截至2024年6月30日的財政年度相比。
- 每股賬面價值爲$25.32,截至2024年9月30日的季度,與2023年9月30日的$23.88相比。
- 2024財年第一季度增加了一臺由HMCA管理的MRI掃描儀,使管理的掃描儀總數達到43台。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。